skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration


Drug development is challenging at the best of times, and made even harder within the realm of rare diseases. Overall, the largest number of drugs has targeted indications within the therapeutic areas of oncology and infectious disease (ID), with malaria being an area of high interest with both therapeutic and preventive interventions.

To get the most accurate and timely intelligence about rare diseases drug development, download your complimentary rare disease report now.


  • The Top 25 Rare Diseases by Total Drugs in Development to Date
  • Current Rare Disease Drug Development Landscape
  • Top 15 Originators of Drugs in Development for Rare Diseases (Includes Non-Rare Disease Drug Counts and % of Portfolio Dedicated to Rare Diseases)
  • Therapeutic Area Distribution of Rare Diseases and Drugs in Development
  • The Top 5 Rare Disease by Drug Count per Therapeutic Area (TA)
  • Rare Infectious Diseases with 10 or More Drugs in Development

Next steps

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Our team is always happy to hear from you. Please call us at:

  • US Toll-Free  : +1 888 670 8900
  • US Toll           : +1 908 547 2200
  • UK & Europe : +44 (20) 337 73737
  • Australia        : +61 2 8705 6907
  • Japan              : +81 3 6273 4260

Or please submit your inquiry via the form so that we can provide you the best possible customer service.

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now: